GlassScriptPrepare for your visit
Chun Bai
Neurology (Psychiatry & Neurology) · Brooklyn, NY · NPI 1609861244
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$2,225.05
in general payments reported to CMS, 2019-2025 · $205 in 2025
The $205 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Who reported paying
General payments only, top 6 by amount.
- Mdd US Operations, LLC $396.05
- Gilead Sciences, INC. $250.00
- Acadia Pharmaceuticals INC $228.72
- Amneal Pharmaceuticals LLC $205.39
- Neurocrine Biosciences, INC. $170.97
- Microvention, INC. $117.07
Drugs and devices associated with these payments
Ultomiris Rytary Gocovri Crexont Ongentys Wakix Vyvgart Hytrulo Kisunla Valtoco Amvuttra Creon Nuplazid
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Chun Bai listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/608168/chun-bai